1. Home
  2. UMH vs RLAY Comparison

UMH vs RLAY Comparison

Compare UMH & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UMH

UMH Properties Inc.

HOLD

Current Price

$15.88

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$8.26

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UMH
RLAY
Founded
1968
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
UMH
RLAY
Price
$15.88
$8.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$17.75
$16.00
AVG Volume (30 Days)
641.3K
2.1M
Earning Date
11-03-2025
11-06-2025
Dividend Yield
5.65%
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$256,272,000.00
$8,355,000.00
Revenue This Year
$10.80
$20.47
Revenue Next Year
$8.34
N/A
P/E Ratio
$203.10
N/A
Revenue Growth
8.96
N/A
52 Week Low
$13.95
$1.78
52 Week High
$19.75
$8.70

Technical Indicators

Market Signals
Indicator
UMH
RLAY
Relative Strength Index (RSI) 64.38 65.59
Support Level $14.96 $7.42
Resistance Level $15.51 $8.70
Average True Range (ATR) 0.25 0.43
MACD 0.08 0.01
Stochastic Oscillator 85.60 68.37

Price Performance

Historical Comparison
UMH
RLAY

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: